Perrigo Faces Patent Suit Over Bausch's Psoriasis Lotion
Law360 (August 31, 2020, 8:16 PM EDT) -- Generic-drug maker Perrigo Israel Pharmaceuticals Ltd. has been hit with a patent infringement lawsuit accusing it of trying to prematurely compete with Bausch Health Ireland Ltd.'s formula for the name-brand plaque psoriasis treatment Duobrii.
In a New Jersey federal court complaint filed Friday, Bausch alleges that Perrigo filed an abbreviated new drug application with the U.S. Food and Drug Administration for a generic version of the topical corticosteroid that would infringe four different patents for Duobrii. Bausch believes Perrigo plans to break into the psoriasis lotion market before the brand-name patents' expiration dates, which are Nov. 2, 2031, for one pair...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!